{"entity":{"type":"insider","cik":"0001825241","url":"/insider/0001825241","json_url":"/insider/0001825241.json","name":"Greenland NFP LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":3,"first":"2021-06-09","last":"2021-06-15","span_basis":"filed_date"},"name_variants":[{"name":"Greenland NFP LLC","source":"filing","n_filings":3,"first_seen":"2021-06-09","last_seen":"2021-06-15"}],"transactions":[{"id":5368560,"accession":"0001062993-21-005709","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001062993-21-005709","line_url":"/filing/0001062993-21-005709","is_derivative":false,"issuer_cik":"0000941976","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0000941976","owner_cik":null,"owner_name":"Greenland NFP LLC; SIMONS JAMES H; Euclidean Capital LLC; Symmetry Group Ltd.; Simons Marilyn; Chhabra Ashvin; Greenland NFP B Ltd.; Greenland FP LLC; Greenland A LLC","owner_display_name":"Greenland NFP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44419.0,"shares_display":"44,419","price_per_share":34.11,"price_display":"34.11","price_state":"stated","total_value":1515132.09,"total_display":"1,515,132.09","total_whole":"1,515,132","shares_owned_after":2496554.0,"shares_owned_after_display":"2,496,554","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-15","scope":"insider","n_lines":5},{"id":5368538,"accession":"0001062993-21-005709","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-21-005709","line_url":"/filing/0001062993-21-005709","is_derivative":false,"issuer_cik":"0000941976","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0000941976","owner_cik":null,"owner_name":"Greenland NFP LLC; SIMONS JAMES H; Euclidean Capital LLC; Symmetry Group Ltd.; Simons Marilyn; Chhabra Ashvin; Greenland NFP B Ltd.; Greenland FP LLC; Greenland A LLC","owner_display_name":"Greenland NFP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21977.0,"shares_display":"21,977","price_per_share":33.8,"price_display":"33.80","price_state":"stated","total_value":742822.6,"total_display":"742,822.60","total_whole":"742,823","shares_owned_after":2521280.0,"shares_owned_after_display":"2,521,280","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-11","filed_date":"2021-06-15","scope":"insider","n_lines":5},{"id":4364285,"accession":"0001062993-21-005572","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001062993-21-005572","line_url":"/filing/0001062993-21-005572","is_derivative":false,"issuer_cik":"0000941976","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0000941976","owner_cik":null,"owner_name":"Chhabra Ashvin; Euclidean Capital LLC; Simons Marilyn; Greenland A LLC; Symmetry Group Ltd.; Greenland NFP LLC; SIMONS JAMES H; Greenland NFP B Ltd.; Greenland FP LLC","owner_display_name":"Chhabra Ashvin","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20633.0,"shares_display":"20,633","price_per_share":32.68,"price_display":"32.68","price_state":"stated","total_value":674286.44,"total_display":"674,286.44","total_whole":"674,286","shares_owned_after":2533517.0,"shares_owned_after_display":"2,533,517","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-11","scope":"insider","n_lines":5},{"id":4364266,"accession":"0001062993-21-005572","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-21-005572","line_url":"/filing/0001062993-21-005572","is_derivative":false,"issuer_cik":"0000941976","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0000941976","owner_cik":null,"owner_name":"Chhabra Ashvin; Euclidean Capital LLC; Simons Marilyn; Greenland A LLC; Symmetry Group Ltd.; Greenland NFP LLC; SIMONS JAMES H; Greenland NFP B Ltd.; Greenland FP LLC","owner_display_name":"Chhabra Ashvin","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39638.0,"shares_display":"39,638","price_per_share":33.64,"price_display":"33.64","price_state":"stated","total_value":1333422.32,"total_display":"1,333,422.32","total_whole":"1,333,422","shares_owned_after":2545002.0,"shares_owned_after_display":"2,545,002","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-11","scope":"insider","n_lines":5},{"id":5528908,"accession":"0001062993-21-005496","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001062993-21-005496","line_url":"/filing/0001062993-21-005496","is_derivative":false,"issuer_cik":"0000941976","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0000941976","owner_cik":null,"owner_name":"Euclidean Capital LLC; Greenland NFP B Ltd.; Greenland NFP LLC; SIMONS JAMES H; Symmetry Group Ltd.; Simons Marilyn; Chhabra Ashvin; Greenland A LLC; Greenland FP LLC","owner_display_name":"Euclidean Capital LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31724.0,"shares_display":"31,724","price_per_share":33.38,"price_display":"33.38","price_state":"stated","total_value":1058947.12,"total_display":"1,058,947.12","total_whole":"1,058,947","shares_owned_after":2567072.0,"shares_owned_after_display":"2,567,072","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-08","filed_date":"2021-06-09","scope":"insider","n_lines":5},{"id":5528897,"accession":"0001062993-21-005496","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-21-005496","line_url":"/filing/0001062993-21-005496","is_derivative":false,"issuer_cik":"0000941976","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0000941976","owner_cik":null,"owner_name":"Euclidean Capital LLC; Greenland NFP B Ltd.; Greenland NFP LLC; SIMONS JAMES H; Symmetry Group Ltd.; Simons Marilyn; Chhabra Ashvin; Greenland A LLC; Greenland FP LLC","owner_display_name":"Euclidean Capital LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30721.0,"shares_display":"30,721","price_per_share":33.62,"price_display":"33.62","price_state":"stated","total_value":1032840.02,"total_display":"1,032,840.02","total_whole":"1,032,840","shares_owned_after":2584736.0,"shares_owned_after_display":"2,584,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-09","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001699382","name":"PMV Pharmaceuticals, Inc.","url":"/issuer/0001699382","role":"Ten percent owner","n_filings":3,"first_seen":"2021-06-09","last_seen":"2021-06-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001825241","retrieved_at":"2026-08-23T18:10:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}